Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study

Authors :: Jason R, Fangusaro
Arzu, Onar-Thomas
Tina Young, Poussaint
Shengjie, Wu
Azra H, Ligon
Neal Ian, Lindeman
Anuradha, Banerjee
Roger, Packer
Lindsay B, Kilburn
Ian F, Pollack
Ibrahim A, Qaddoumi
Paul Graham, Fisher
Girish, Dhall
Patricia Ann, Baxter
Susan G, Kreissman
L Austin, Doyle
Malcolm A, Smith
Maryam, Fouladi
Ira J, Dunkel
Source :: Neuro Oncol
Publication Year :: 2022
Publisher :: Oxford University Press (OUP), 2022.

Tools